UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

Cancer biomarkers : section A of Disease markers, 2018-01, Vol.22 (1), p.143-149

2018

Volltextzugriff (PDF)

Survival analysis according to lymph nodes dissection and adjuvant therapy types in gastric cancer: A retrospective multicenter cohort study

Journal of oncological science, 2019-12, Vol.5 (3), p.80-84

2019

Volltextzugriff (PDF)

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (4), p.2601-2605

2012

Volltextzugriff (PDF)

ABO and Rh blood groups and risk of colorectal adenocarcinoma

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (12), p.6097-6100

2012

Volltextzugriff (PDF)

Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast

Archives of gynecology and obstetrics, 2011-08, Vol.284 (2), p.405-409

2011

Volltextzugriff (PDF)

Is HER2 overexpression sufficient for optimal response to Pertuzumab?

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (4), p.2565-2566

2012

Volltextzugriff (PDF)

Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab

Oncology research and treatment, 2013-10, Vol.36 (10), p.554-558

2013

Volltextzugriff (PDF)

Is programmed cell death ligand-1 expression required for optimal response to anti-PD-1 antibody in cancer

Journal of B.U. ON., 2014-04, Vol.19 (2), p.577-578

2014

Volltextzugriff (PDF)

Small cell carcinoma of the urinary bladder with hypercalcemia

Medical oncology (Northwood, London, England), 2012-06, Vol.29 (2), p.827-828

2012

Volltextzugriff (PDF)

Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study

Journal of gastrointestinal cancer, 2021-06, Vol.52 (2), p.634-642

2021

Volltextzugriff (PDF)

Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?

World journal of gastroenterology : WJG, 2013-01, Vol.19 (1), p.144-146

2013

Volltextzugriff (PDF)

The real life outcomes of modified docetaxel and cisplatin plus fluorourasil regimen in patients with metastatic gastric cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15548-e15548

2016

Volltextzugriff (PDF)

A rare case: Branch retinal vein occlusion associated with the use of tamoxifen

Journal of cancer research and therapeutics, 2019-07, Vol.15 (3), p.722-724

2019

Volltextzugriff (PDF)

What is the mechanism of progression with trastuzumab treatment--escape or resistance?

Asian Pacific journal of cancer prevention : APJCP, 2012-01, Vol.13 (11), p.5915-5916

2012

Volltextzugriff (PDF)

Does zoledronic acid have additive effect on suppression of plasma estrogen levels?

Asian Pacific journal of cancer prevention : APJCP, 2013-01, Vol.14 (1), p.607-608

2013

Volltextzugriff (PDF)

Do Patient Characteristics And Duration of Response to Hormonal Therapy Predict Outcomes of Post-Docetaxel Abirateron Acetate Treatment in Prostate Cancer?

Uluslararası hematologi-onkoloji dergisi, 2019-01, Vol.29 (3), p.139-146

IMAMOGLU, GOKSEN INANC

2019

Volltextzugriff (PDF)

Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma

Molecular and clinical oncology, 2017-08, Vol.7 (2), p.267-274

2017

Volltextzugriff (PDF)

Does Zoledronic Acid Have Additive Effect on Suppression of Plasma Estrogen Levels ?

Asian Pacific journal of cancer prevention : APJCP, 2013, Vol.14 (1), p.607-608

2013

Volltextzugriff (PDF)

Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

Journal of cancer research and clinical oncology, 2012-12, Vol.138 (12), p.2145-2151

2012

Volltextzugriff (PDF)

Serum 25-hydroxy Vitamin D Status is Not Related to Osteopenia/Osteoporosis Risk in Colorectal Cancer Survivors

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (8), p.3377-3381

2014

Volltextzugriff (PDF)

Docetaxel and Cisplatin in First Line Treatment of Patients with Unknown Primary Cancer: A Multicenter Study of the Anatolian Society of Medical Oncology

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (4), p.1581-1584

2014

Volltextzugriff (PDF)

What is the Mechanism of Progression with Trastuzumab Treatment - Escape or Resistance?

Asian Pacific journal of cancer prevention : APJCP, 2012, Vol.13 (11), p.5915-5916

2012

Volltextzugriff (PDF)

Treatment Approaches in 102 Elderly Patients With Non-Small Cell Lung Cancer

World journal of oncology, 2015-02, Vol.6 (1), p.276-282

2015

Volltextzugriff (PDF)

Earthquake disaster impact on health care of cancer patients: Single center experience

Turkish journal of internal medicine (Online), 2023-10, Vol.5 (4), p.234-239

2023

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHepato-Gastroenterology

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(54)
Berichte
(4)

Sprache

Englisch
(49)
Koreanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(17)
Oncology
(17)
Female
(9)
Gastric Cancer
(8)
Medicine
(8)
Medicine & Public Health
(8)
Breast Cancer
(7)
Breast Neoplasms - Drug Therapy
(7)
Chemotherapy
(7)
Middle Aged
(7)
Retrospective Studies
(7)
Adult
(5)
Aged
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Breast Neoplasms - Pathology
(5)
Internal Medicine
(5)
Treatment Outcome
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Survival analysis according to lymph nodes dissection and adjuvant therapy types in gastric cancer: A retrospective multicenter cohort study

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

ABO and Rh blood groups and risk of colorectal adenocarcinoma

Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast

Is HER2 overexpression sufficient for optimal response to Pertuzumab?

Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab

Is programmed cell death ligand-1 expression required for optimal response to anti-PD-1 antibody in cancer

Small cell carcinoma of the urinary bladder with hypercalcemia

Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study

Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?

The real life outcomes of modified docetaxel and cisplatin plus fluorourasil regimen in patients with metastatic gastric cancer

A rare case: Branch retinal vein occlusion associated with the use of tamoxifen

What is the mechanism of progression with trastuzumab treatment--escape or resistance?

Does zoledronic acid have additive effect on suppression of plasma estrogen levels?

Do Patient Characteristics And Duration of Response to Hormonal Therapy Predict Outcomes of Post-Docetaxel Abirateron Acetate Treatment in Prostate Cancer?

Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma

Does Zoledronic Acid Have Additive Effect on Suppression of Plasma Estrogen Levels ?

Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

Serum 25-hydroxy Vitamin D Status is Not Related to Osteopenia/Osteoporosis Risk in Colorectal Cancer Survivors

Docetaxel and Cisplatin in First Line Treatment of Patients with Unknown Primary Cancer: A Multicenter Study of the Anatolian Society of Medical Oncology

What is the Mechanism of Progression with Trastuzumab Treatment - Escape or Resistance?

Treatment Approaches in 102 Elderly Patients With Non-Small Cell Lung Cancer

Earthquake disaster impact on health care of cancer patients: Single center experience

Aktive Filter

Suchergebnisse filtern